Search Within

Robert Nicolais Stuver

Formats
  1. Meeting Abstract (44)
  2. Journal Article (11)
  3. Review (9)
  4. Research Letter (8)
  5. Correspondence (1)
Groups
  1. GME, Medicine (73)
  2. Graduate Medical Education (73)
  3. Hematology-Oncology Fellows (73)
  4. Center for Hematologic Malignancies (65)
  5. Department of Medicine (65)
  6. Hematologic Malignancies, Division of (65)

More Groups

People
  1. Steven Horwitz (53)
  2. Alison Moskowitz (48)
  3. Zachary Epstein-Peterson (34)
  4. William Johnson (30)
  5. Paola Ghione (27)
  6. Ariela Noy (26)

More People

Years
  1. 2025 (6)
  2. 2024 (27)
  3. 2023 (24)
  4. 2022 (13)
  5. 2021 (3)
Publications
  1. Blood (43)
  2. Blood Advances (6)
  3. British Journal of Haematology (3)
  4. Haematologica (2)
  5. Journal of Clinical Oncology (2)
  6. Leukemia and Lymphoma (2)

More Publications

Publishers
  1. American Society of Hematology (50)
  2. John Wiley & Sons (3)
  3. American Society of Clinical Oncology (2)
  4. Ferrata Storti Foundation (2)
  5. Springer (2)
  6. Taylor & Francis Group (2)

More Publishers

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cumulative incidence of myeloid neoplasms in patients with nodal T-follicular helper cell lymphoma
    Meeting Abstract

    Stuver, R.; Ganesan, N.; Dogan, A.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Lewis, N.; Moskowitz, A.; Shah, G. L.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Novel causal inference method estimates treatment effects of contemporary drugs in a global cohort of patients with relapsed and refractory mature T-cell and NK-cell neoplasms
    Meeting Abstract

    Koh, M. J.; Boussi, L.; Han, J. X.; Peng, L.; Sorial, M. N.; Eche-Ugwu, I. J.; Miranda, E.; Chiattone, C.; Stuver, R.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • PD-1 blockade before autologous stem cell transplantation improves outcomes in relapsed/refractory classic Hodgkin lymphoma: Results from a multicenter cohort
    Meeting Abstract

    Desai, S. H.; Merryman, R. W.; Shah, H.; Pederson, L. D.; Geyer, S. M.; Ganesan, N.; Chang, T.; Othman, T.; Falade, A. S.; Shah, G. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Predicting toxicities in older adults with non-Hodgkin lymphoma (NHL) receiving systemic chemotherapy: A prospective geriatric assessment (GA) study
    Meeting Abstract

    Torka, P.; Drill, E.; Ganesan, N.; Oliveros, M.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-life experience with lenalidomide plus anti-CD20 antibodies for the treatment of patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL)
    Meeting Abstract

    Cassanello, G.; Rivas-Delgado, A.; Luna De Abia, A.; Corona, M.; Luttwak, E.; Okwali, M.; Isgor, I.; Galera, P.; Boardman, A. P.; Caron, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab
    Research Letter

    Stuver, R.; Vardhana, S. A.; Bedmutha, A.; Chan, K. K.; Mirtcheva-Trocheva, R.; Nosov, A.; Schòˆder, H.; Moskowitz, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Few and far between: Clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas
    Review

    Stuver, R.; Epstein-Peterson, Z. D.; Horwitz, S. M.
    Haematologica (2023)

    Fulltext@MSK | Save